SODIUM BUTABARBITAL Drug Patent Profile
✉ Email this page to a colleague
When do Sodium Butabarbital patents expire, and when can generic versions of Sodium Butabarbital launch?
Sodium Butabarbital is a drug marketed by Hikma, Ivax Sub Teva Pharms, Lannett, and Marshall Pharma. and is included in nine NDAs.
The generic ingredient in SODIUM BUTABARBITAL is butabarbital sodium. There are nine drug master file entries for this compound. Additional details are available on the butabarbital sodium profile page.
Summary for SODIUM BUTABARBITAL
US Patents: | 0 |
Applicants: | 4 |
NDAs: | 9 |
Raw Ingredient (Bulk) Api Vendors: | 28 |
Clinical Trials: | 1 |
Patent Applications: | 3,690 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SODIUM BUTABARBITAL at DailyMed |
Recent Clinical Trials for SODIUM BUTABARBITAL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Federal University of São Paulo | Phase 4 |
Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for SODIUM BUTABARBITAL
US Patents and Regulatory Information for SODIUM BUTABARBITAL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hikma | SODIUM BUTABARBITAL | butabarbital sodium | TABLET;ORAL | 085418-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lannett | SODIUM BUTABARBITAL | butabarbital sodium | TABLET;ORAL | 085881-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Ivax Sub Teva Pharms | SODIUM BUTABARBITAL | butabarbital sodium | TABLET;ORAL | 084040-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |